{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:35Z","timestamp":1792025195878,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81920108027"],"award-info":[{"award-number":["No. 81920108027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 32470971"],"award-info":[{"award-number":["Grant No. 32470971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funding for Chongqing Young and Middle-Aged Medical Excellence Team","award":["Y2024003"],"award-info":[{"award-number":["Y2024003"]}]},{"name":"National Outstanding Youth Reserve Talent Training Project","award":["2025DBXM006"],"award-info":[{"award-number":["2025DBXM006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The role of gut microbiota and their metabolites in the progression of hepatocellular carcinoma (HCC) has garnered increasing attention. Although\n                    <jats:italic>Alistipes<\/jats:italic>\n                    , a genus frequently reported as a beneficial bacterium, has been associated with antitumor effects and enhanced efficacy of cancer therapies, its specific functions and underlying mechanisms in HCC remain poorly defined. In this study, 16S rDNA sequencing revealed a marked decrease in the abundance of\n                    <jats:italic>Alistipes<\/jats:italic>\n                    in fecal samples from HCC patients compared to healthy controls, a finding that was also observed in HCC mouse models. Additionally, iso-15:0, an important fatty acid metabolite derived from\n                    <jats:italic>Alistipes<\/jats:italic>\n                    , was found to be significantly reduced in the feces of both HCC patients and HCC mouse models. Functional experiments demonstrated that iso-15:0 effectively suppresses the proliferation and migration of HCC cells in vitro and in vivo. Mechanistically, iso-15:0 inhibits the activation of the PI3K\/AKT signaling pathway by interfering with G protein-coupled receptor (GPCR) downstream signaling, specifically through the G\u03b2\u03b3 subunits. To further explore the potential for the clinical application of iso-15:0, we have developed a biomimetic nanodelivery system (3R\/RGD\/M1@iso-15:0 LNP) that markedly improves the delivery efficiency and therapeutic efficacy of iso-15:0 in vivo. Our findings elucidate for the first time that iso-15:0, derived from\n                    <jats:italic>Alistipes<\/jats:italic>\n                    , suppresses HCC progression by restricting the G\u03b2\u03b3\u2013PI3K\/AKT signaling axis, highlighting its potential as a novel therapeutic strategy for HCC.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00622-1","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:11Z","timestamp":1792022831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alistipes-derived monomethyl branched-chain fatty acid iso-15:0 suppresses hepatocellular carcinoma progression by inhibiting G\u03b2\u03b3\/PI3K\/AKT signaling"],"prefix":"10.1186","volume":"7","author":[{"given":"Juan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-9449","authenticated-orcid":false,"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"10504","key":"622_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, et al. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406(10504):731\u201378. https:\/\/doi.org\/10.1016\/s0140-6736(25)01042-6.","journal-title":"Lancet"},{"issue":"10360","key":"622_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/s0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet (London, England). 2022;400(10360):1345\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(22)01200-4.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"622_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3350\/cmh.2024.0857","volume":"31","author":"C Li","year":"2025","unstructured":"Li C, Cai C, Wang C, Chen X, Zhang B, Huang Z. Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer. Clin Mol Hepatol. 2025;31(2):350\u201381. https:\/\/doi.org\/10.3350\/cmh.2024.0857.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"622_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68(6):1014\u201323. https:\/\/doi.org\/10.1136\/gutjnl-2017-315084.","journal-title":"Gut"},{"issue":"10","key":"622_CR5","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.cmet.2025.09.001","volume":"37","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu W, Wong CC, Song Q, Zhang X, Zhou Q, et al. Catenibacter iummitsuokai promotes hepatocellular carcinogenesis by binding to hepatocytes and generating quinolinic acid. Cell Metab. 2025;37(10):1998-2013.e7. https:\/\/doi.org\/10.1016\/j.cmet.2025.09.001.","journal-title":"Cell Metab"},{"issue":"11","key":"622_CR6","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","volume":"187","author":"Q Nie","year":"2024","unstructured":"Nie Q, Luo X, Wang K, Ding Y, Jia S, Zhao Q, et al. Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway. Cell. 2024;187(11):2717-34.e33. https:\/\/doi.org\/10.1016\/j.cell.2024.03.034.","journal-title":"Cell"},{"issue":"6","key":"622_CR7","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol. 2023;79(6):1352\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.005.","journal-title":"J Hepatol"},{"issue":"1","key":"622_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2500099","volume":"17","author":"H Wu","year":"2025","unstructured":"Wu H, Chen J, Guo S, Deng J, Zhou Z, Zhang X, et al. Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease. Gut Microbes. 2025;17(1):2500099. https:\/\/doi.org\/10.1080\/19490976.2025.2500099.","journal-title":"Gut Microbes"},{"key":"622_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906. https:\/\/doi.org\/10.3389\/fimmu.2020.00906.","journal-title":"Front Immunol"},{"issue":"3","key":"622_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chom.2024.02.001","volume":"32","author":"YX Xu","year":"2024","unstructured":"Xu YX, Liu LD, Zhu JY, Zhu SS, Ye BQ, Yang JL, et al. Alistipes indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate hyperuricemia. Cell Host Microbe. 2024;32(3):366-81.e9. https:\/\/doi.org\/10.1016\/j.chom.2024.02.001.","journal-title":"Cell Host Microbe"},{"issue":"34","key":"622_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309473","volume":"11","author":"KY Zheng","year":"2024","unstructured":"Zheng KY, Gao B, Wang HJ, He JG, Chen HS, Hu ZL, et al. Melatonin ameliorates depressive-like behaviors in ovariectomized mice by improving tryptophan metabolism via inhibition of gut microbe Alistipes inops. Adv Sci. 2024;11(34):e2309473. https:\/\/doi.org\/10.1002\/advs.202309473.","journal-title":"Adv Sci"},{"issue":"10","key":"622_CR12","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","volume":"6","author":"M Rau","year":"2018","unstructured":"Rau M, Rehman A, Dittrich M, Groen AK, Hermanns HM, Seyfried F, et al. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United European gastroenterology journal. 2018;6(10):1496\u2013507. https:\/\/doi.org\/10.1177\/2050640618804444.","journal-title":"United European gastroenterology journal"},{"issue":"Pt 8","key":"622_CR13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1099\/ijs.0.64318-0","volume":"56","author":"Y Song","year":"2006","unstructured":"Song Y, K\u00f6n\u00f6nen E, Rautio M, Liu C, Bryk A, Eerola E, et al. Alistipes onderdonkii sp. nov. and Alistipes shahii sp. nov., of human origin. Int J Syst Evol Microbiol. 2006;56(Pt 8):1985\u201390. https:\/\/doi.org\/10.1099\/ijs.0.64318-0.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"12","key":"622_CR14","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1099\/ijsem.0.000617","volume":"65","author":"AN Shkoporov","year":"2015","unstructured":"Shkoporov AN, Chaplin AV, Khokhlova EV, Shcherbakova VA, Motuzova OV, Bozhenko VK, et al. Alistipes inops sp. nov. and Coprobacter secundus sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2015;65(12):4580\u20138. https:\/\/doi.org\/10.1099\/ijsem.0.000617.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"2","key":"622_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1078\/072320203322346029","volume":"26","author":"M Rautio","year":"2003","unstructured":"Rautio M, Eerola E, V\u00e4is\u00e4nen-Tunkelrott ML, Molitoris D, Lawson P, Collins MD, et al. Reclassification of Bacteroides putredinis (Weinberg et al., 1937) in a new genus Alistipes gen. nov., as Alistipes putredinis comb. nov., and description of Alistipes finegoldii sp. nov., from human sources. Syst Appl Microbiol. 1937;26(2):182\u20138. https:\/\/doi.org\/10.1078\/072320203322346029.","journal-title":"Syst Appl Microbiol"},{"issue":"1","key":"622_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1099\/ijsem.0.003778","volume":"70","author":"M Sakamoto","year":"2020","unstructured":"Sakamoto M, Ikeyama N, Ogata Y, Suda W, Iino T, Hattori M, et al. Alistipes communis sp. nov., Alistipes dispar sp. nov. and Alistipes onderdonkii subsp. vulgaris subsp. nov., isolated from human faeces, and creation of Alistipes onderdonkii subsp. onderdonkii subsp. nov. Int J Syst Evol Microbiol. 2020;70(1):473\u201380. https:\/\/doi.org\/10.1099\/ijsem.0.003778.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"6","key":"622_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.animal.2022.100545","volume":"16","author":"LL Sun","year":"2022","unstructured":"Sun LL, Liu L, Brenna JT, Wu ZH, Ma L, Bu DP. Odd- and branched-chain fatty acids in milk fat from Holstein dairy cows are influenced by physiological factors. Animal\u202f: an international journal of animal bioscience. 2022;16(6):100545. https:\/\/doi.org\/10.1016\/j.animal.2022.100545.","journal-title":"Animal : an international journal of animal bioscience"},{"issue":"48","key":"622_CR18","doi-asserted-by":"publisher","first-page":"18674","DOI":"10.1021\/acs.jafc.3c06300","volume":"71","author":"S Mao","year":"2023","unstructured":"Mao S, Liu Z, Tian Y, Li D, Gao X, Wen Y, et al. Branched-long-chain monomethyl fatty acids: are they hidden gems? J Agric Food Chem. 2023;71(48):18674\u201384. https:\/\/doi.org\/10.1021\/acs.jafc.3c06300.","journal-title":"J Agric Food Chem"},{"issue":"11","key":"622_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41589-018-0132-2","volume":"14","author":"M Wallace","year":"2018","unstructured":"Wallace M, Green CR, Roberts LS, Lee YM, McCarville JL, Sanchez-Gurmaches J, et al. Enzyme promiscuity drives branched-chain fatty acid synthesis in adipose tissues. Nat Chem Biol. 2018;14(11):1021\u201331. https:\/\/doi.org\/10.1038\/s41589-018-0132-2.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"622_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065308","volume":"8","author":"Q Cai","year":"2013","unstructured":"Cai Q, Huang H, Qian D, Chen K, Luo J, Tian Y, et al. 13-methyltetradecanoic acid exhibits antitumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3. PLoS ONE. 2013;8(6):e65308. https:\/\/doi.org\/10.1371\/journal.pone.0065308.","journal-title":"PLoS ONE"},{"issue":"3","key":"622_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.urolonc.2010.04.011","volume":"30","author":"T Lin","year":"2012","unstructured":"Lin T, Yin X, Cai Q, Fan X, Xu K, Huang L, et al. 13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells. Urol Oncol. 2012;30(3):339\u201345. https:\/\/doi.org\/10.1016\/j.urolonc.2010.04.011.","journal-title":"Urol Oncol"},{"issue":"3","key":"622_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1158\/0008-5472.CAN-18-2726","volume":"60","author":"Z Yang","year":"2000","unstructured":"Yang Z, Liu S, Chen X, Chen H, Huang M, Zheng J. Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid. Can Res. 2000;60(3):505\u20139.","journal-title":"Can Res"},{"key":"622_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511x-4-29","volume":"4","author":"S Wongtangtintharn","year":"2005","unstructured":"Wongtangtintharn S, Oku H, Iwasaki H, Inafuku M, Toda T, Yanagita T. Incorporation of branched-chain fatty acid into cellular lipids and caspase-independent apoptosis in human breast cancer cell line, SKBR-3. Lipids Health Dis. 2005;4:29. https:\/\/doi.org\/10.1186\/1476-511x-4-29.","journal-title":"Lipids Health Dis"},{"key":"622_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.656441","volume":"12","author":"JD Secor","year":"2021","unstructured":"Secor JD, Fligor SC, Tsikis ST, Yu LJ, Puder M. Free fatty acid receptors as mediators and therapeutic targets in liver disease. Front Physiol. 2021;12:656441. https:\/\/doi.org\/10.3389\/fphys.2021.656441.","journal-title":"Front Physiol"},{"issue":"6640","key":"622_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6220","volume":"380","author":"C Mao","year":"2023","unstructured":"Mao C, Xiao P, Tao XN, Qin J, He QT, Zhang C, et al. Unsaturated bond recognition leads to biased signal in a fatty acid receptor. Science (New York, NY). 2023;380(6640):eadd6220. https:\/\/doi.org\/10.1126\/science.add6220.","journal-title":"Science (New York, NY)"},{"key":"622_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-025-02331-6","author":"T Chang","year":"2025","unstructured":"Chang T, Zheng Y, Jiang M, Jia S, Bai J, Zheng Z, et al. Peptide codes for organ-selective mRNA delivery. Nat Mater. 2025;25(1):146\u201359.\u00a0https:\/\/doi.org\/10.1038\/s41563-025-02331-6.","journal-title":"Nat Mater"},{"key":"622_CR27","doi-asserted-by":"publisher","unstructured":"Zhang J, Gu B, Wu S, Liu L, Gao Y, Yao Y, et al. M1 macrophage-biomimetic targeted nanoparticles containing oxygen self-supplied enzyme for enhancing the chemotherapy. Pharmaceutics. 2023;15(9):2243.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics15092243.","DOI":"10.3390\/pharmaceutics15092243"},{"key":"622_CR28","doi-asserted-by":"publisher","unstructured":"Cossu J, Thoreau F, Boturyn D. Multimeric RGD-based strategies for selective drug delivery to tumor tissues. Pharmaceutics. 2023;15(2):525. https:\/\/doi.org\/10.3390\/pharmaceutics15020525.","DOI":"10.3390\/pharmaceutics15020525"},{"key":"622_CR29","doi-asserted-by":"publisher","unstructured":"Yu PC, Yue CX, Dong WZ, Hao CY, Qiao YF, Liu D, et al. Cancer Immunotherapy via Disruption of Integrin \u03b1v\u03b23 and CD47 Costabilization on Cancer Cell Surface. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026;13(2):e01602. https:\/\/doi.org\/10.1002\/advs.202501602.","DOI":"10.1002\/advs.202501602"},{"key":"622_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03166","volume":"9","author":"L Shao","year":"2018","unstructured":"Shao L, Ling Z, Chen D, Liu Y, Yang F, Li L. Disorganized gut microbiome contributed to liver cirrhosis progression: a meta-omics-based study. Front Microbiol. 2018;9:3166. https:\/\/doi.org\/10.3389\/fmicb.2018.03166.","journal-title":"Front Microbiol"},{"issue":"1","key":"622_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"622_CR32","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.Can-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee MH. AKT as a Therapeutic Target for Cancer. Can Res. 2019;79(6):1019\u201331. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2738.","journal-title":"Can Res"},{"issue":"1","key":"622_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38985-6","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu H, Zhang Q, He X, Jiang M, Wang S, Yan X, et al. Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84. Nat Commun. 2023;14(1):3271. https:\/\/doi.org\/10.1038\/s41467-023-38985-6.","journal-title":"Nat Commun"},{"key":"622_CR34","doi-asserted-by":"publisher","unstructured":"Lin H, Ma C, Cai K, Guo L, Wang X, Lv L, et al. Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis. Science (New York, NY). 2025;388(6746):eado4188. https:\/\/doi.org\/10.1126\/science.ado4188.","DOI":"10.1126\/science.ado4188"},{"issue":"5","key":"622_CR35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2021-326789.","journal-title":"Gut"},{"issue":"6","key":"622_CR36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2019.11.005","volume":"179","author":"KI Hilgendorf","year":"2019","unstructured":"Hilgendorf KI, Johnson CT, Mezger A, Rice SL, Norris AM, Demeter J, et al. Omega-3 fatty acids activate ciliary FFAR4 to control adipogenesis. Cell. 2019;179(6):1289-305.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.11.005.","journal-title":"Cell"},{"key":"622_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00115","volume":"5","author":"DY Oh","year":"2014","unstructured":"Oh DY, Walenta E. Omega-3 fatty acids and FFAR4. Front Endocrinol. 2014;5:115. https:\/\/doi.org\/10.3389\/fendo.2014.00115.","journal-title":"Front Endocrinol"},{"issue":"1","key":"622_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.00041.2018","volume":"100","author":"I Kimura","year":"2020","unstructured":"Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free Fatty Acid Receptors in Health and Disease. Physiol Rev. 2020;100(1):171\u2013210. https:\/\/doi.org\/10.1152\/physrev.00041.2018.","journal-title":"Physiol Rev"},{"issue":"2","key":"622_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189266","volume":"1880","author":"L Li","year":"2025","unstructured":"Li L, An Z, Lin C, Xu Q, Tang C. An update on regulation and function of G protein-coupled receptors in cancer: A promising strategy for cancer therapy. Biochim Biophys Acta. 2025;1880(2):189266. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189266.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"622_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00622-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00622-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00622-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:12Z","timestamp":1792022832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00622-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00622-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The human study protocol received approval from the Medical Ethics Committee of Chongqing University Cancer Hospital (Approval No.: CZLL2025-171\u2013001). All participants provided written informed consent prior to enrollment. All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and the Declaration of Helsinki.Animal experiments were approved by the Institutional Animal Care and Use Committee of Chongqing University Cancer Hospital (Approval No.: CQCH-LAE-A0000202105) and were conducted following institutional guidelines and the principles of the 3Rs.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the author(s).","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"211"}}